Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study. Meyer A, Semenzato L, Zureik M, Weill A, et al. Aliment Pharmacol Ther 2021;54:160-166.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meyer A, Semenzato L, Zureik M, Weill A, et al. Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study. Aliment Pharmacol Ther 2021;54:160-166.
PMID: 34110040